Autism spectrum disorder: Advances in evidence-based practice

CMAJ. Canadian Medical Association Journal

Volumn 186, Issue 7, 2014, Pages 509-519

  Anagnostou, Evdokia ^b   Zwaigenbaum, Lonnie ^c   Szatmari, Peter ^d,f   Fombonne, Eric ^g,h   Fernandez, Bridget A ⁱ   Woodbury Smith, Marc ^j   Brian, Jessica ^b   Bryson, Susan ^k,l   Smith, Isabel M ^k,l   Drmic, Irene ^d,j   Buchanan, Janet A ^e   Roberts, Wendy ^a,d   Scherer, Stephen W ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b University of Toronto   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^g MONTREAL CHILDREN S HOSPITAL   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^j MCMASTER UNIVERSITY   (Canada)

^k DALHOUSIE UNIVERSITY   (Canada)

^l DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; MELATONIN; RISPERIDONE;

AGGRESSION; ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; COMORBIDITY; COMPULSION; COPY NUMBER VARIATION; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; EVIDENCE BASED PRACTICE; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; HYPERACTIVITY; IRRITABILITY; MICROARRAY ANALYSIS; PATHOGENESIS; PATIENT ASSESSMENT; PATIENT IDENTIFICATION; PHARMACEUTICAL CARE; PRIMARY MEDICAL CARE; PSYCHOLOGIC ASSESSMENT; REVIEW; SLEEP DISORDER; SYMPTOM ASSESSMENT; TREATMENT OUTCOME;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED PRACTICE; GENETIC TESTING; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84896518969     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.121756     Document Type: Review

References (89)

1. Prevalence of autism spectrum disorders Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012;61:1-19.
2. Elsabbagh M, Divan G, Koh YJ, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5:160-79.
3. Zwaigenbaum L, Bryson SE, Szatmari P, et al. Sex differences in children with autism spectrum disorder identified within a high-risk infant cohort. J Autism Dev Disord 2012;42:2585-96.
4. Ozonoff S, Young GS, Carter A, et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics 2011;128:e488-95.
5. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2012;22:229-37.
6. Jiang YH, Yuen RK, Jin X, et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet 2013;93:249-63.
7. Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368-72.
8. Scherer SW, Dawson G. Risk factors for autism: translating genomic discoveries into diagnostics. Hum Genet 2011;130:123-48.
9. Carter MT, Scherer SW. Autism spectrum disorder in the genetics clinic: a review. Clin Genet 2013;83:399-407.
10. Buxbaum JD, Daly MJ, Devlin B, et al.; The Autism Sequencing Consortium. Large-scale, high-throughput sequencing in autism spectrum disorders. Neuron 2012;76:1052-6.
11. Duncan AM, Chodirker B. Use of array genomic hybridization technology for constitutional genetic diagnosis in Canada. Paediatr Child Health 2011;16:211-2.
12. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64.
13. Newschaffer CJ, Croen LA, Fallin MD, et al. Infant siblings and the investigation of autism risk factors. J Neurodev Disord 2012; 4:7.
14. Offit P. Autism's false prophets: bad science, risky medicine, and the search for a cure. 1st ed. New York (NY): Columbia University Press; 2008.
15. Fombonne E, Zakarian R, Bennett A, et al. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006;118:e139-50.
16. Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011;68:1095-102.
17. Levy SE, Mandell DS, Schultz RT. Autism. Lancet 2009; 374: 1627-38.
18. Zwaigenbaum L. Screening, risk and early identification of autism spectrum disorders. In: Amaral D DG, Geschwind DH, editors. Autism spectrum disorders. Oxford (UK): Oxford University Press; 2009.
19. Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007;120:1183-215.
20. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol 1996;38:191-202.
21. Kielinen M, Rantala H, Timonen E, et al. Associated medical disorders and disabilities in children with autistic disorder: a population-based study. Autism 2004;8:49-60.
22. Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 2009; 46:1-8.
23. Miles JH, Takahashi TN, Bagby S, et al. Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A 2005;135:171-80.
24. Boddaert N, Zilbovicius M, Philipe A, et al. MRI findings in 77 children with non-syndromic autistic disorder. PLoS ONE 2009; 4:e4415.
25. Zecavati N, Spence SJ. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep 2009; 9:129-36.
26. Buie T, Campbell DB, Fuchs GJ III, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 2010;125(Suppl 1):S1-18.
27. Spence SJ, Schneider MT. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res 2009;65:599-606.
28. Mahoney WJ, Szatmari P, MacLean JE, et al. Reliability and accuracy of differentiating pervasive developmental disorder subtypes. J Am Acad Child Adolesc Psychiatry 1998;37:278-85.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington (VA): 2013.
30. DSM-5 proposed criteria for autism spectrum disorder designed to provide more accurate diagnosis and treatment [press release]. Arlington (VA): American Psychiatric Association; 2012 Mar. 27. Available: www.dsm5.org/Documents/12- 03%20 Autism %20Spectrum %20Disorders%20-%20DSM5.pdf (accessed 2013 Dec. 9)
31. Huerta M, Bishop SL, Duncan A, et al. Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders. Am J Psychiatry 2012;169:1056-64.
32. Lord C, Rutter M, DiLavore P, et al. Autism diagnostic observation schedule (ADOS) manual. Los Angeles (CA): Western Psychological Services; 2003.
33. Gotham K, Risi S, Dawson G, et al. A replication of the autism diagnostic observation schedule (ADOS) revised algorithms. J Am Acad Child Adolesc Psychiatry 2008;47:642-51.
34. Schopler E, Reichler RJ, DeVellis RF, et al. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord 1980;10:91-103.
35. Chlebowski C, Green JA, Barton ML, et al. Using the childhood autism rating scale to diagnose autism spectrum disorders. J Autism Dev Disord 2010;40:787-99.
36. Lord C, Rutter M, Le Couteur A. Autism diagnostic interviewrevised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659-85.
37. Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 2010;125:e17-23.
38. Smith IM, Koegel RL, Koegel LK, et al. Effectiveness of a novel community-based early intervention model for children with autistic spectrum disorder. Am J Intellect Dev Disabil 2010; 115: 504-23.
39. Peters-Scheffer N, Didden R, Korzilius H, et al. Cost comparison of early intensive behavioral intervention and treatment as usual for children with autism spectrum disorder in The Netherlands. Res Dev Disabil 2012;33:1763-72.
40. Zwaigenbaum L, Bryson S, Lord C, et al. Clinical assessment and management of toddlers with suspected autism spectrum disorder: insights from studies of high-risk infants. Pediatrics 2009; 123:1383-91.
41. Zwaigenbaum L, Bryson S, Garon N. Early identification of autism spectrum disorders. Behav Brain Res 2013;251:133-46.
42. Dahinten S, Ford L. Validation of the Nipissing District developmental screen for use with children and toddlers working paper. Vancouver (BC): University of British Columbia; 2004; Available: www.effectivepractice.org/site/ ywd-effectivepractice/assets/pdf/2c-British-Columbia-Validation-Study.pdf (accessed 2013 Dec. 9).
43. Williams R, Clinton J, Biscaro A. Ontario and the enhanced 18- month well-baby visit: trying new approaches. Paediatr Child Health 2008;13:850-6.
44. Pandey J, Verbalis A, Robins DL, et al. Screening for autism in older and younger toddlers with the modified checklist for autism in toddlers. Autism 2008;12:513-35.
45. Wetherby AM, Brosnan-Maddox S, Peace V, et al. Validation of the infant-toddler checklist as a broadband screener for autism spectrum disorders from 9 to 24 months of age. Autism 2008; 12: 487-511.
46. Wetherby AM, Goldstein H, Cleary J, et al. Early identification of children with communication disorders: concurrent and predictive validity of the CSBS developmental profile. Infants Young Child 2003;16:161-74.
47. Chlebowski C, Robins DL, Barton ML, et al. Large-scale use of the modified checklist for autism in low-risk toddlers. Pediatrics 2013; 131:e1121-7.
48. Eaves LC, Wingert H, Ho HH. Screening for autism: agreement with diagnosis. Autism 2006;10:229-42.
49. Kleinman JM, Robins DL, Ventola PE, et al. The modified checklist for autism in toddlers: a follow-up study investigating the early detection of autism spectrum disorders. J Autism Dev Disord 2008;38:827-39.
50. Nygren G, Sandberg E, Gillstedt F, et al. A new screening programme for autism in a general population of Swedish toddlers. Res Dev Disabil 2012;33:1200-10.
51. Robins DL, Fein D, Barton ML, et al. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord 2001;31:131-44.
52. Snow AV, Lecavalier L. Sensitivity and specificity of the modified checklist for autism in toddlers and the social communication questionnaire in preschoolers suspected of having pervasive developmental disorders. Autism 2008;12:627-44.
53. Pierce K, Carter C, Weinfeld M, et al. Detecting, studying, and treating autism early: the one-year well-baby check-up approach. J Pediatr. 2011;159:458-65.
54. Corsello C, Hus V, Pickles A, et al. Between a ROC and a hard place: decision making and making decisions about using the SCQ. J Child Psychol Psychiatry 2007;48:932-40.
55. Oosterling I, Rommelse N, de Jonge M, et al. How useful is the Social Communication Questionnaire in toddlers at risk of autism spectrum disorder? J Child Psychol Psychiatry 2010; 51: 1260-8.
56. Simonoff E, Pickles A, Charman T, et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 2008;47:921-9.
57. Mazzone L, Ruta L, Reale L. Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges. Ann Gen Psychiatry 2012;11:16.
58. National standards report: the National Standards Project addressing the need for evidence-based practice guidelines for autism spectrum disorders. Randolph (MA): National Autism Center; 2009.
59. Cooper JO, Heron TE, Heward WL. Applied behavior analysis. Columbus (OH): Merrill Publishing; 1987.
60. Reichow B. Overview of meta-analyses on early intensive behavioral intervention for young children with autism spectrum disorders. J Autism Dev Disord 2012;42:512-20.
61. Peters-Scheffer N, Didden R, Korzilius H, et al. A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with autism spectrum disorders. Res Autism Spectr Disord 2011;5:60-9.
62. Virués-Ortega J. Applied behavior analytic intervention for autism in early childhood: meta-analysis, meta-regression and doseresponse meta-analysis of multiple outcomes. Clin Psychol Rev 2010;30:387-99.
63. Reichow B, Barton EE, Boyd BA, et al. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012;(10): CD009260.
64. Makrygianni MK, Reed P. A meta-analytic review of the effectiveness of behavioural early intervention programs for children with autistic spectrum disorders. Res Autism Spectr Disord 2010; 4: 577-93.
65. Perry A, Cummings A, Geier JD, et al. Predictors of outcome for children receiving intensive behavioral intervention in a large, community-based program. Res Autism Spectr Disord 2011;5: 592-603.
66. Koegel RL, Koegel L.K, O'Neill R. Generalization in the treatment of autism. In: Spradlin LVMJE, editor. Generalization strategies in the treatment of communication disorders. Toronto (ON): Decker; 1989:116-31.
67. Carter AS, Messinger DS, Stone WL, et al. A randomized controlled trial of Hanen's "More Than Words" in toddlers with early autism symptoms. J Child Psychol Psychiatry 2011;52: 741-52.
68. Perry A, Cummings A, Dunn Geier J, et al. Effectiveness of intensive behavioral intervention in a large, community-based program. Res Autism Spectr Disord 2008;2:621-42.
69. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002; 347:314-21.
70. King BH, Hollander E, Sikich L, et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 2009;66:583-90.
71. Research Units on Pediatric Psychopharmacology Autism Network. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry 2005;162:1361-9.
72. Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev 2007;(1)CD005040.
73. Ching H, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012;(5):CD009043.
74. Malow BA, Byars K, Johnson K, et al. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics 2012;130(Suppl 2):S106-24.
75. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009;124:1533-40.
76. Posey DJ, Aman MG, McCracken JT, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry 2007;61:538-44.
77. Harfterkamp M, van de Loo-Neus G, Minderaa RB, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/ hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 2012;51:733-41.
78. Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 2006; 45: 1196-205.
79. Handen BL, Sahl R, Hardan AY. Guanfacine in children with autism and/or intellectual disabilities. J Dev Behav Pediatr 2008; 29:303-8.
80. Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011;53:783-92.
81. McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 2005;162:1142-8.
82. Reed HE, McGrew SG, Artibee K, et al. Parent-based sleep education workshops in autism. J Child Neurol 2009;24:936-45.
83. Vriend JL, Corkum PV, Moon EC, et al. Behavioral interventions for sleep problems in children with autism spectrum disorders: current findings and future directions. J Pediatr Psychol 2011; 36:1017-29.
84. Anagnostou E, Hansen R. Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications. Curr Opin Pediatr 2011;23:621-7.
85. Billstedt E, Gillberg IC, Gillberg C. Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. [published in erratum in J Autism Dev Disord 2007;37:1822]. J Autism Dev Disord 2005; 35:351-60.
86. Howlin P. Outcomes in autism spectrum disorders. In: Volkmar FR, Paul R, Klin A, et al., editors. Handbook of autism and pervasive developmental disorders. 3rd ed. Hoboken (NJ): Wiley; 2005: 201-22.
87. Stoddart K, Burke L, Muskat B, et al. Diversity in Ontario's youth and adults with autism spectrum disorders: complex needs in unprepared systems. Toronto (ON): The Redpath Centre; 2013.
88. Ehninger D, Silva AJ. Genetics and neuropsychiatric disorders: treatment during adulthood. Nat Med 2009;15:849-50.
89. Novarino G, El-Fishawy P, Kayserili H, et al. Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 2012;338:394-7.